The value of serum IL-4 to predict the survival of MDS patients

BACKGROUND: Immune indicators are routinely used for the detection of myelodysplastic syndrome (MDS), but these are not utilized as a reference indicator to assess prognosis in MDS-related prognostic evaluation systems, such as the World Health Organizational prognostic scoring system, the internati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaoyun, Xu, Xintong, Zheng, Likun, Ding, Kai, Yang, Chun, Huang, Jincheng, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811803/
https://www.ncbi.nlm.nih.gov/pubmed/36600245
http://dx.doi.org/10.1186/s40001-022-00948-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811803/
https://www.ncbi.nlm.nih.gov/pubmed/36600245
http://dx.doi.org/10.1186/s40001-022-00948-w

Ejemplares similares